Cost-effectiveness analysis, welfare economics, and the societal perspective: a reply

被引:0
|
作者
Bengt Liljas
机构
[1] AstraZeneca,Department of Economics
[2] Lund University,undefined
关键词
Cost-effectiveness analysis; QALYs; Welfare economics; Societal perspective; D61; D81; I10;
D O I
暂无
中图分类号
学科分类号
摘要
A critical question in cost-effectiveness analysis (CEA) is what costs should be included. In an earlier paper in this journal, I argued that the same principle (internal consistency) that has been applied to the discussion about future non-medical costs should also be applied to the case when survival is not affected. Internal consistency in this case implies that a cost should only be included if its corresponding utility is also included. As Quality-Adjusted Life-Years can rarely be considered to be consistent with a broad definition of utility, I built a case for recommending to not including the costs for changes in consumption and absence from work (whereas changes in the productivity at work may still be included) when applying a welfare theoretic foundation. As one of several parts of building this case, and to further highlight the elements of importance, I constructed a simple welfare theoretic model. Unfortunately, this model did not take the envelope theorem into account (which was correctly pointed out by Prof. Friedrich Breyer). However, most of the arguments still hold and the policy implications are actually even confirmed in the analysis by Prof. Friedrich Breyer. Building on these results, a related and equally interesting question is what the implications are on the so-called societal perspective. It seems as if a societal perspective in CEA may not be consistent with a welfare theoretic foundation. However, even if such a foundation is not seen as important, it may still be of interest—for reasons of internal consistency—to take a societal perspective on both costs and benefits.
引用
收藏
页码:597 / 598
页数:1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF PSYCHOTHERAPY - REPLY
    KRUPNICK, JL
    PINCUS, HA
    AMERICAN JOURNAL OF PSYCHIATRY, 1993, 150 (10): : 1571 - 1571
  • [42] Cost-effectiveness analyses - Reply
    Prosser, LA
    Stinnett, AA
    Goldman, L
    Weinstein, MC
    ANNALS OF INTERNAL MEDICINE, 2001, 135 (05) : 382 - 383
  • [43] COST-EFFECTIVENESS CONTROVERSY - REPLY
    WHITTINGTON, R
    GOA, K
    PHARMACOECONOMICS, 1995, 8 (01) : 82 - 83
  • [44] COST-EFFECTIVENESS OF PSRO - REPLY
    FULCHIERO, A
    MILLER, S
    FOLEY, CR
    BALLANTINE, HT
    AMOROSINO, CS
    NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (06): : 325 - 325
  • [45] Cost-effectiveness of PCV20 to Prevent Pneumococcal Disease in the Pediatric Population: A German Societal Perspective Analysis
    Ta, An
    Kuehne, Felicitas
    Laurenz, Maren
    von Eiff, Christof
    Warren, Sophie
    Perdrizet, Johnna
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (06) : 1333 - 1358
  • [46] Neurosurgical economics and cost-effectiveness INTRODUCTION
    Schmidt, Meic H.
    Boop, Frederick A.
    Martin, Neil A.
    Slotkin, Jonathan R.
    NEUROSURGICAL FOCUS, 2018, 44 (05)
  • [47] Diagnosis of pulmonary embolism: A cost-effectiveness analysis - Reply
    Doyle, NM
    Gardner, M
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (06) : 2178 - 2178
  • [48] A cost-effectiveness analysis of endoscopic third ventriculostomy - Reply
    Garton, HJL
    Kestle, JRW
    Cochrane, DD
    Steinbok, P
    NEUROSURGERY, 2003, 52 (06) : 1507 - 1508
  • [49] A Payer's Perspective on the Cost-Effectiveness of Gastric Bypass Surgery REPLY
    Ikramuddin, Sayeed
    Swan, Therese
    Klingman, C. David
    Minshall, Michael E.
    AMERICAN JOURNAL OF MANAGED CARE, 2009, 15 (11): : 828 - +
  • [50] Perspective and Costing in Cost-Effectiveness Analysis, 1974–2018
    David D. Kim
    Madison C. Silver
    Natalia Kunst
    Joshua T. Cohen
    Daniel A. Ollendorf
    Peter J. Neumann
    PharmacoEconomics, 2020, 38 : 1135 - 1145